Publications

Immunoglobulin replacement to prevent infections in people with haematological malignancies and haematopoietic stem cell transplantation

Chai KL. et al, (2024), Cochrane Database of Systematic Reviews, 2024

Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines.

Callum J. et al, (2024), Chest

Mitigating the impact of blood shortages in England.

Chowdhury F. et al, (2024), Br J Haematol

Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.

Gibbs VN. et al, (2024), Cochrane Database Syst Rev, 1

Network Meta-analysis results: Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis

Sandercock J. and Estcourt L., (2023)

Clinical decision support versus a paper-based protocol for massive transfusion: Impact on decision outcomes in a simulation study.

Sanderson BJ. et al, (2023), Transfusion, 63, 2225 - 2233

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.

LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators None. et al, (2023), JAMA, 330, 1745 - 1759

Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis.

Stadler E. et al, (2023), Lancet Microbe, 4, e883 - e892

Simvastatin in Critically Ill Patients with Covid-19.

REMAP-CAP Investigators None. et al, (2023), N Engl J Med

Transfusion Thresholds in Hematologic Malignancy Receiving Intensive Therapies - Risk of bias assessment

Estcourt L., (2023)

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors.

Nurmi V. et al, (2023), J Infect Dis, 228, 245 - 250

Interventions for chronic kidney disease in people with sickle cell disease.

Roy NB. et al, (2023), Cochrane Database Syst Rev, 8

Antiplatelet agents for the treatment of adults with COVID-19.

Fischer A-L. et al, (2023), Cochrane Database Syst Rev, 7

Continuation of therapeutic dose heparin for critically ill patients with COVID-19.

Bradbury CA. et al, (2023), Intensive Care Med, 49, 873 - 875

Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.

Desborough MJR. et al, (2023), Lancet Neurol, 22, 557 - 567

Study protocol: UK 2022 Comparative Audit of Acute Upper Gastrointestinal Bleeding (AUGIB) and the use of Blood

Nigam G. et al, (2023)

Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews.

Lewis SR. et al, (2023), Cochrane Database Syst Rev, 6

Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.

Gibbs VN. et al, (2023), Cochrane Database Syst Rev, 6

Convalescent plasma for people with COVID-19: a living systematic review.

Iannizzi C. et al, (2023), Cochrane Database Syst Rev, 5

Accelerated waning of the humoral response to COVID-19 vaccines in obesity.

van der Klaauw AA. et al, (2023), Nat Med, 29, 1146 - 1154

Cookies on this website